ENTRY       D11025                      Drug
NAME        Idursulfase beta (INN);
            Idursulfase beta (genetical recombination) (JAN);
            Hunterase (TN)
FORMULA     C2689H4051N699O793S13
EXACT_MASS  59238.4521
MOL_WEIGHT  59274.9897
SEQUENCE    SETQANSTTD ALNVLLIIVD DLRPSLGCYG DKLVRSPNID QLASHSLLFQ NAFAQQAVCA
            PSRVSFLTGR RPDTTRLYDF NSYWRVHAGN FSTIPQYFKE NGYVTMSVGK VFHPGISSNH
            TDDSPYSWSF PPYHPSSEKY ENTKTCRGPD GELHANLLCP VDVLDVPEGT LPDKQSTEQA
            IQLLEKMKTS ASPFFLAVGY HKPHIPFRYP KEFQKLYPLE NITLAPDPEV PDGLPPVAYN
            PWMDIRQRED VQALNISVPY GPIPVDFQRK IRQSYFASVS YLDTQVGRLL SALDDLQLAN
            STIIAFTSDH GWALGEHGEW AKYSNFDVAT HVPLIFYVPG RTASLPEAGE KLFPYLDPFD
            SASQLMEPGR QSMDLVELVS LFPTLAGLAG LQVPPRCPVP SFHVELCREG KNLLKHFRFR
            DLEEDPYLPG NPRELIAYSQ YPRPSDIPQW NSDKPSLKDI KIMGYSIRTI DYRYTVWVGF
            NPDEFLANFS DIHAGELYFV DSDPLQDHNM YNDSQGGDLF QLLMP
            (Disulfide bridge: 146-159, 397-407)
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB16
            Product: D11025<JP>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (iduronate-2-sulfatase)
  TYPE      Enzyme replacement therapy product
COMMENT     Treatment of Hunter syndrome
TARGET      IDS* [HSA_VAR:3423v1] [HSA:3423] [KO:K01136]
  PATHWAY   hsa00531(3423)  Glycosaminoglycan degradation
            hsa04142(3423)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB16 Idursulfase beta
                  D11025  Idursulfase beta (INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D11025  Idursulfase beta (INN); Idursulfase beta (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Sulfatases
                IDS* [HSA_VAR:3423v1]
                 D11025  Idursulfase beta (INN) &lt;JP&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11025
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11025
DBLINKS     CAS: 1271734-34-9
            PubChem: 350078344
///
